John P. Hamill

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Doylestown, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John Hamill
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John P. Hamill

Form 4 holding SrVP/CFO/Prin Fin & Acct Ofcr

Aprea Therapeutics, Inc.

Security class
Pre-Funded Warrant
Shares / value
30,978
Estimated value
$24,999
Report date
31 Mar 2026
Price
$0.8070
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SrVP/CFO/Prin Fin & Acct Ofcr

Aprea Therapeutics, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
40,380
Estimated value
Report date
12 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John P. Hamill

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .